JOURNAL OF CHEMICAL RESEARCH 2011 643
Table 4 Different solvents employed in the synthesis of
celiprolol base (7)
washed with ice water until the washings were acid-free. The product
was dried in the air, giving a white crystalline powder (21.2 g, 84.7%).
The intermediate 17 was recrystallised from diisopropyl ether
Entry
Solventa
Reaction time/h Yield/%b
1
and ethyl acetate (5:1), m.p. 105.3–107.5 °C. H NMR (400 MHz,
CDCl3): δ 12.04 (bs, 1 H), 8.01 (d, J = 2.0 Hz, 1 H), 7.26 (dd,
J = 2.0 Hz, J = 7.5 Hz, 1 H), 6.87 (d, J = 7.5 Hz, 1 H), 6.40 (bs, 1H),
3.38 (q, J = 10.0 Hz, 4 H), 2.61 (s, 3H), 1.22 (t, J = 10.0 Hz, 6H).
Anal. Calcd for C13H18N2O3: C, 62.38; H, 7.25; N, 11.19. Found: C,
62.35; H, 7.31; N, 11.17%.
1
2
3
4
5
Water
24
8
71.3
92.3
79.5
75.2
68.9
Ethanol
Acetone
Dichloromethane
Neat
8
8
8
Celiprolol base (7): The intermediate 17 (37.5 g, 0.15 mol), epi-
chlorohydrin (47.1 g, 0.30 mol), sodium hydroxide (8.0 g, 0.20 mol),
and DMSO (5 mL) were cplaced in a reaction vessel. The solution
was stirred for 12 h at 50 °C, cooled to room temperature, and filtered.
The excess epichlorohydrin was recovered from the filtrate by con-
centration under vacuum. Toluene (200 mL) was added to the residue
to extract the product. The organic layer was washed with dilute
sodium hydroxide (200 mL, 8%), then saturated sodium chloride
solution (200 mL). The toluene was removed by water bath under
reduced pressure. Ethanol (200 mL) and tert-butylamine (109.5 g,
1.5 mol) were poured into the residue, which was then refluxed for 8 h
to allow the reaction to proceed to completion. Acetone (100 mL) was
added to the mixture, which had been concentrated under vacuum, to
precipitate the product. The mixture was filtered off and washed with
acetone and water. The product was dried in the air, giving a white
crystalline powder 7 (43.0 g ,76%), m.p. 116.4–118.0 °C, lit.5 117–
118 °C, TLC: homogeneous with authentic specimen. Anal. Calcd for
C20H33N3O4: C, 63.30; H, 8.76; N, 11.07. Found: C, 63.25; H, 8.80; N,
11.04%.
Celiprolol hydrochloride (2): Celiprolol base 7 (38 g, 0.1 mol) was
dissolved in 170 mL acetone and cooled to room temperature.
Moisture-free hydrogen chloride dried with concentrated sulfuric acid
was injected into the reaction vessel continuously until the pH was
5.5–6.0 ensuring the product was completely precipitated. The sepa-
rated solid was filtered and washed with acetone, and dried in air to
give the title compound 2 (37.0 g, 81.3%), m.p. 197.8–198.4 °C, lit.6
197–198 °C. 1H NMR (400 MHz, CDCl3) δ 7.85 (d, J = 2.0 Hz, 1 H),
7.59 (dd, J = 2.0, 9.0 Hz, 1 H), 6.86 (d, J = 9.0 Hz, 1 H), 6.36 (bs, 1
H), 4.15–4.20 (m, 1 H), 3.85–4.05 (m, 2 H), 3.40 (q, J = 10.0 Hz, 4
H), 2.96–3.10 (m, 2 H), 2.60 (s, 3 H), 2.55 (bs, 2 H), 2.20 (bs, 1 H),
1.47 (s, 9 H), 1.20 (t, J = 10.0 Hz, 6 H).
a Condition: tert-butylamine (109.5 g, 1.5 mol) and 200 mL
solvent, reflux, 8h.
b Isolated yield.
Experimental
All reagents were obtained commercially and were used without
further purification. Melting points were determined on a WSR-2
1
capillary melting point apparatus and are uncorrected. H NMR data
were recorded on a Bruker 400 MHz spectrometer operating at
400 (1H) MHz in CDCl3 solutions and TMS as internal standard.
Elemental analyses were recorded on a Vario E1 III elementary
analyser.
4-Nitrophenyl acetate (9): 4-Nitrochlorobenzene (14) (15.8 g,
0.10 mol) was taken up in 15% aqueous sodium hydroxide (66.7 g,
0.25 mol) in a 400-mL autoclave. The mixture was heated at 140 °C
for 10 h, after which time the starting material had been consumed as
shown by TLC (developing solvent, EtOAc/hexane = 1:4, V/V), the
pressure during reaction was 0.3 MPa). The mixture was then cooled
to room temperature, and the resulting orange solid was filtered and
washed with EtOAc (10 mL). The crude product and acetic anhydride
(20.4 g, 0.2 mol) were stirred in a flask and heated to 80 °C for 30 min
and then cooled. Water was added to precipitate the product. The
precipitated product was filtered off, washed with water and dried in
the air, giving a pale yellow crystalline powder (16.4 g, 90.5%), m.p.
1
77.2–78.1 °C, lit.10 77–78 °C. H NMR (400 MHz, CDCl3): δ 8.28
(d, J = 9.0 Hz, 2H), 7.29 (d, J = 9.0 Hz, 2H), 2.36 (s, 3H).
4-Aminophenyl acetate (15): 4-Nitrophenyl acetate (9) (18.0 g,
0.1 mol) in ethyl acetate (100 mL) was hydrogenated at 0.5 MPa
with 5% Pd/C (1.0 g) at 65 °C. The reaction was monitored by
TLC (developing solvent, EtOAc/hexanes = 1:4, V/V). After complete
reduction (6.5 h), the catalyst was filtered, and the filtrate was
concentrated under vacuum to afford the amino compound (15)
We thank the National Natural Science Foundation of China
(20776127), the National Key Technology R&D Program
(2007BAI34B07), the Natural Science Foundation of the
Zhejiang Province (Y4090045, R4090358).
1
(13.9 g, 92%), m.p. 72.4–74.2 °C, lit.11 73 °C. H NMR (400 MHz,
CDCl3): δ 6.82 (d, J = 8.8 Hz, 2 H), 6.59 (d, J = 8.8 Hz, 2 H), 3.62 (bs,
2 H), 2.22 (s, 3 H).
4-(3,3-Diethylureido) phenyl acetate (16): The acetate (15) (49.0 g,
0.33 mol), sodium bicarbonate (56.0 g, 0.67 mol) and acetone (80 mL)
were combined and stirred. DECC (50 mL, 0.37 mol) was added
dropwise with a cooling bath maintaining the temperature below
30 °C. After the addition was complete, the temperature of the mixture
was kept at 30 °C for 12 h. Then the mixture was refluxed for 5 h,
after which time the starting material 15 had been consumed as shown
by TLC (developing solvent, EtOAc/hexanes = 1:1, V/V). A saturated
solution of sodium bicarbonate (200 mL) was added to the mixture,
which was stirred for a further 5 min. The oily layer was separated
from the mixture, and its pH was adjusted to 6.0 by the addition of
concentrated hydrochloric acid. The precipitated product was filtered
off and washed with water. The product was dried in the air, giving
a white solid (74.0 g, 90.8%), m.p. 133.2–134.7 °C. 1H NMR
(400 MHz, CDCl3): δ 8.10 (s, 1 H), 7.17 (d, J = 7.8 Hz, 2H), 6.63
(d, J = 7.8 Hz, 2H), 3.33(q, J = 10.0 Hz, 4H), 2.20 (s, 3 H), 1.08
(t, J = 10.0 Hz, 6H). Anal. Calcd for C13H18N2O3: C, 62.38; H, 7.25; N,
11.19. Found: C, 62.32; H, 7.35; N, 11.14%.
Received 8 October 2011; accepted 20 October 2011
Paper 1100920 doi: 10.3184/174751911X13192995267028
Published online: 22 November 2011
References
1
2
3
4
J. Elks, and C.R. Ganellin, Dictionary of drugs, Chapman and Hall, Ltd,
New York, 1990; Vol. 1.
R.C. Allen, Annual reports in medicinal chemistry, ed. M.B. Denis,
Academic Press, New York, 1984; Vol. 19, p. 313.
G. Thomas, Medicinal chemistry, 2nd edn, JohnWiley & Sons Ltd, London,
2007; Chap.8, pp. 285–289.
D.J. Mazzo, C.L. Obetz and J.E. Shuster, Analytical profiles of drug
substances, ed. K. Florey, Academic Press, New York, 1991,Vol. 20,
pp. 237–301.
5
6
G. Zolss, Arzneim. Forsch. 1983, 33, 1.
R.A. Joshi, M.K. Gurjar, N.K.Tripathy and M.S.Chorghade, Org. Process
Res. Dev., 2001, 5, 176.
7
8
R. Martin, Org. Prep. Proc. Int., 1992, 24, 369.
L. Ji, X.Y. Mao, C. Qian and X.Z. Chen, Zhejiang Univ. (Eng. Sci.), 2011,
45, 563.
3-(3-Acetyl-4-hydroxyphenyl)-1,1-diethyl-urea (17): Compound 16
(25.0 g, 0.10 mol), anhydrous aluminum chloride (40.0 g, 0.30 mol)
and sodium chloride (20.0 g, 0.34 mol) were stirred and heated slowly
to 140 °C. The mixture was left at this temperature for 3 h, and then
allowed to cool to 60 °C. Ice water (100 mL) was poured carefully
into the mixture, and the resulting white solid was filtered off and
9
D.J. Crouse, S.L. Hurlbut and M.S. Wheeler, J. Org. Chem., 1981, 46,
374.
10 F.M. Menger and M.J. McCreery, J. Am. Chem. Soc., 1974, 96, 121.
11 R.J. Rahaim and R.E. Maleczka, Org. Lett., 2005, 7, 5087.